Category: Biotechnology
United States Biotechnology
-
Biotech Research and Development - US Industry Market Research Report with Recession Risk Analysis & Forecasts
... Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of company, concentration segmentation, business structure, customer type, state and MSA, profitability, financial ratios, ... Read More
-
U.S. Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service, By Products (Biologics, Biosimilars), By Type, By Scale Of Operation, By Therapeutic Area, And Segment Forecasts, 2025 - 2030
... to a new report by Grand View Research, Inc.The U.S. biopharmaceuticals contract manufacturing market is growing due to the rising demand for biologics and biosimilars, which address complex diseases with innovative therapies. Advancements in manufacturing ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Cancer Type, Application, End User, and Region - Analysis and Forecast, 2025-2035
... prostate cancer in the U.S. In addition, the focus of business leaders is establishing a deep understanding to address the unmet needs in clinical research to understand the U.S. prostate cancer testing market. Market Lifecycle ... Read More
-
U.S. Laboratory Informatics Market Size, Share & Trends Analysis Report By Product (LIMS, ELN), By Delivery Mode (Cloud-based, On-premise), By Component (Software, Service), By End Use, And Segment Forecasts, 2025 - 2030
... 2030, according to a new report by Grand View Research, Inc. The rising demand for lab automation and information management activities owing to the increasing amount of data generated by research laboratories is one of ... Read More
-
Scientific Research & Development in the US - Industry Market Research Report
... government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over the past five years. While the COVID-19 pandemic provided increased government funding ... Read More
-
Cell Therapy in the US - Industry Market Research Report
... over a decade ago, cell therapy developers have been at the forefront of life sciences innovation, with interest and investment pouring into the field. But, the current regulatory environment hasn't kept up with the rapidly ... Read More
-
Cryogenic Biobanking Services in the US - Industry Market Research Report
... house samples, companies in this industry catalog biospecimens by genetic or environmental characteristics for use by researchers who require specimens with these traits. Biobanks have become an increasingly vital tool in medical research by producing ... Read More
-
Biotechnology Product Manufacturing
... the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199
... and forecasts that will save countless hours of research. Key Findings: Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes Industry (U.S.) to reach $143,690,753,961 by 2031. Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
... that will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $77,985,958,669 by 2031. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.), including Average EBITDA, ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Plant Cell Culture Equipment
... 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$784.8 Million by the end ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by the end ... Read More
-
Tissue Engineering
... CAGR of 12.5% over the analysis period 2024-2030. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Extracellular Matrix Market, By Component Type (Proteins, Glycoproteins, Proteoglycans, Other ECM molecules), By Application (Regenerative Medicine, Tissue Engineering, Wound Healing, Drug Delivery, Cancer Research, Others), By Source (Animal-Derived ECM, Human-Derived ECM, Synthetic ECM), By End-User (Research Institutes and Academic Centers, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics), By Product Type (Hydrogels, Scaffolds, Decellularized ECM, ECM Analogs, Others), By Technology (3D Bioprinting, Nanotechnology, Cell Culture Techniques, Genetic Engineering, Others), By Therapeutic Area (Orthopedics, Dermatology, Cardiology, Neurology, Oncology, Others), By Function (Structural Support, Cellular Communication, Cell Adhesion, Signal Transduction), By Biomaterial Type (Natural ECM, Synthetic ECM), By End-Use Industry (Healthcare, Research and Development, Cosmetics, Pharmaceuticals, Others), By Geography (North America, Latin America, Europe, Middle East & Africa,
... proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes. The global extracellular matrix market is witnessing significant growth due to the increasing prevalence of chronic ... Read More
-
Biotechnology in the United States
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, ... Read More
-
Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... free of cells and cellular debris. It is yellow in color due to presence of bilirubin. It is generally collected from the commercial slaughterhouse from cattle. It has wide range of applications in vaccine production, ... Read More
-
2025 U.S. Infectious Disease Molecular Diagnostics Market Shares and Forecasts for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
... and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of leading market players and start-up firms developing innovative products Specific ... Read More
-
2025 Global Infectious Disease Molecular Diagnostics Market Shares and Forecasts for 100 Tests: US, Europe, Japan - Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
... Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of leading market players and start-up firms developing innovative products ... Read More
-
Scientific Research & Development in the US - Industry Market Research Report
... government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over the past five years. While the COVID-19 pandemic provided increased government funding ... Read More
Research Assistance
